Amgen (AMGN) Consolidated Net Income (2009 - 2026)

Amgen has reported Consolidated Net Income for 18 years, with the latest figure at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Consolidated Net Income rose 5.14% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $7.8 billion (up 31.47% YoY), and the FY2025 full-year result was $7.7 billion, up 88.53% from the prior year.
• Consolidated Net Income for Q1 2026 stood at $1.8 billion, up from $1.3 billion in the prior quarter.
• The five-year high for Consolidated Net Income was $3.2 billion in Q3 2025, with the low at -$113.0 million in Q1 2024.
• Average Consolidated Net Income over 5 years is $1.6 billion, with a median of $1.5 billion recorded in 2022.
• Year-over-year, Consolidated Net Income plunged 103.98% in 2024 and jumped 1630.97% in 2025.
• Tracing AMGN's Consolidated Net Income over 5 years: stood at $1.6 billion in 2022, then sank by 52.54% to $767.0 million in 2023, then decreased by 18.25% to $627.0 million in 2024, then jumped by 112.6% to $1.3 billion in 2025, then soared by 36.46% to $1.8 billion in 2026.
• The last three Consolidated Net Income figures came in at $1.8 billion (Q1 2026), $1.3 billion (Q4 2025), and $3.2 billion (Q3 2025), per Business Quant data.

Peer Comparison